 Glioblastoma multiforme GBM is an aggressive and deadly form of brain cancer. For those afflicted, the prognosis is bleak but biopharmaceutical company CNS Pharmaceuticals NASDAQ:CNSP Inc is providing hope with the progress the company has been making in its clinical trials involving the powerful novel chemotherapy drug Berubicin. 